Compare Stocks: NUWE, IRIX, ADGM, and MBAI

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ADGM Adagio Medical	$0.48 -7.2%	$0.56	$0.36 ▼ $2.58	$10.72M	-0.09	221,870 shs	97,110 shs
IRIX IRIDEX	$0.67 +2.8%	$0.80	$0.61 ▼ $1.65	$11.77M	0.62	74,421 shs	75,438 shs
MBAI Check-Cap	$6.39 +0.8%	$7.46	$6.01 ▼ $27.44	$8.79M	0.67	29,244 shs	6,265 shs
NUWE Nuwellis	$0.90 -17.7%	$1.56	$0.71 ▼ $172.90	$3.27M	0.23	4.54 million shs	1.51 million shs

7 Stocks That Could Lead the Next Market Boom

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ADGM Adagio Medical	0.00%	-13.99%	-23.91%	-29.04%	-70.40%
IRIX IRIDEX	0.00%	+1.52%	-12.03%	-41.48%	-48.06%
MBAI Check-Cap	0.00%	-0.16%	-20.32%	-36.16%	+638,999,900.00%
NUWE Nuwellis	0.00%	+15.89%	-19.91%	-80.80%	-99.35%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ADGM Adagio Medical	$0.48 -7.2%	$0.56	$0.36 ▼ $2.58	$10.72M	-0.09	221,870 shs	97,110 shs
IRIX IRIDEX	$0.67 +2.8%	$0.80	$0.61 ▼ $1.65	$11.77M	0.62	74,421 shs	75,438 shs
MBAI Check-Cap	$6.39 +0.8%	$7.46	$6.01 ▼ $27.44	$8.79M	0.67	29,244 shs	6,265 shs
NUWE Nuwellis	$0.90 -17.7%	$1.56	$0.71 ▼ $172.90	$3.27M	0.23	4.54 million shs	1.51 million shs

7 Stocks That Could Lead the Next Market Boom

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ADGM Adagio Medical	0.00%	-13.99%	-23.91%	-29.04%	-70.40%
IRIX IRIDEX	0.00%	+1.52%	-12.03%	-41.48%	-48.06%
MBAI Check-Cap	0.00%	-0.16%	-20.32%	-36.16%	+638,999,900.00%
NUWE Nuwellis	0.00%	+15.89%	-19.91%	-80.80%	-99.35%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ADGM Adagio Medical	2.25	Hold	$3.50	625.39% Upside
IRIX IRIDEX	2.00	Hold	$3.00	347.76% Upside
MBAI Check-Cap	1.00	Sell	N/A	N/A
NUWE Nuwellis	1.00	Sell	N/A	N/A

Current Analyst Ratings Breakdown

Latest NUWE, IRIX, ADGM, and MBAI Analyst Ratings

Date	Company	Brokerage	Action	Rating
9/4/2026	IRIX IRIDEX	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
8/21/2026	IRIX IRIDEX	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
8/19/2026	ADGM Adagio Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
8/6/2026	IRIX IRIDEX	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
8/5/2026	ADGM Adagio Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
7/21/2026	MBAI Check-Cap	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
7/20/2026	ADGM Adagio Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
7/17/2026	IRIX IRIDEX	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
7/1/2026	ADGM Adagio Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
7/1/2026	IRIX IRIDEX	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
6/24/2026	NUWE Nuwellis	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)

(Data available from 9/20/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ADGM Adagio Medical	$600K	17.86	N/A	N/A	$0.59 per share	0.82
IRIX IRIDEX	$52.67M	0.22	N/A	N/A	($0.06) per share	-11.17
MBAI Check-Cap	N/A	N/A	$3.97 per share	1.61	$3.30 per share	N/A
NUWE Nuwellis	$8.27M	0.40	N/A	N/A	$55.31 per share	0.02

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ADGM Adagio Medical	-$25.08M	-$1.48	N/A	N/A	N/A	N/A	-661.85%	-73.35%	11/11/2026 (Estimated)
IRIX IRIDEX	-$4.44M	-$0.20	N/A	N/A	N/A	-6.88%	N/A	-12.55%	11/17/2026 (Estimated)
MBAI Check-Cap	$4.14M	-$14.07	N/A	N/A	N/A	N/A	N/A	N/A	N/A
NUWE Nuwellis	-$17.52M	-$132.59	N/A	N/A	N/A	-123.38%	-623.14%	-147.34%	11/11/2026 (Estimated)

Latest NUWE, IRIX, ADGM, and MBAI Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/18/2026	Q2 2026	IRIX IRIDEX	-$0.01	-$0.07	-$0.06	-$0.07	$13.59 million	$12.57 million
8/13/2026	Q2 2026	NUWE Nuwellis	-$23.80	-$26.64	-$2.84	-$26.64	$2.42 million	$1.97 million
8/11/2026	Q2 2026	ADGM Adagio Medical	-$0.27	-$0.30	-$0.03	-$0.30	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
ADGM Adagio Medical	N/A	N/A	N/A	N/A	N/A
IRIX IRIDEX	N/A	N/A	N/A	N/A	N/A
MBAI Check-Cap	N/A	N/A	N/A	N/A	N/A
NUWE Nuwellis	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ADGM Adagio Medical	4.00	1.41	1.15
IRIX IRIDEX	N/A	1.82	1.08
MBAI Check-Cap	N/A	0.05	0.05
NUWE Nuwellis	N/A	1.97	1.54

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ADGM Adagio Medical	48.08%
IRIX IRIDEX	20.10%
MBAI Check-Cap	1.07%
NUWE Nuwellis	3.13%

Insider Ownership

Company	Insider Ownership
ADGM Adagio Medical	7.81%
IRIX IRIDEX	8.60%
MBAI Check-Cap	0.48%
NUWE Nuwellis	1.60%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ADGM Adagio Medical	41	22.21 million	20.48 million	N/A
IRIX IRIDEX	108	17.57 million	16.05 million	Optionable
MBAI Check-Cap	85	1.38 million	1.37 million	N/A
NUWE Nuwellis	38	3.65 million	3.59 million	Not Optionable

NUWE, IRIX, ADGM, and MBAI Headlines

Recent News About These Companies

Nuwellis Appoints Brian Johnson As Director Of Quality And Regulatory Affairs

September 17 at 1:19 PM | rttnews.com

Nuwellis reports 31 Aquadex console sales in 2026, expanding recurring revenue opportunity

September 17 at 1:19 PM | msn.com

Nuwellis Reports Strong Aquadex Console Adoption, with 31 Aquadex SmartFlow Consoles Sold Year-to-Date, Meaningfully Expanding Recurring Revenue Opportunity

September 17 at 8:30 AM | globenewswire.com

Nuwellis Strengthens Organization with Appointment of Brian Johnson as Director of Quality and Regulatory Affairs

September 16, 2026 | globenewswire.com

Nuwellis, Inc. (NASDAQ:NUWE) Short Interest Up 86.1% in August

September 16, 2026 | americanbankingnews.com

Nuwellis Advances Financial Efficiency Strategy with Improved Gross Margins

September 9, 2026 | globenewswire.com

Nuwellis Highlights Aquadex Growth in Updated Presentation

August 27, 2026 | theglobeandmail.com

Nuwellis Expands Critical Care Portfolio Through Strategic Commercial Agreement with Atrility Medical

August 25, 2026 | globenewswire.com

Nuwellis Inc (NUWE) (Q2 2026) Earnings Call Highlights: Revenue Surges 14% and Installed Base ...

August 14, 2026 | finance.yahoo.com

Nuwellis, Inc. (NUWE) Q2 2026 Earnings Call Prepared Remarks Transcript

August 13, 2026 | seekingalpha.com

Nuwellis Reports Second Quarter 2026 Financial Results and Business Highlights Focused on Double Digit Revenue Growth and Expanded Gross Margin

August 13, 2026 | globenewswire.com

Nuwellis Accelerates Digital Transformation of the Aquadex® Platform with EHR Connectivity and Enhanced User Interface

August 11, 2026 | finance.yahoo.com

Nuwellis Strengthens Product Development Organization with Appointment of Dale Brady as Principal R&D Engineer

August 6, 2026 | globenewswire.com

Nuwellis Announces Next-Generation Aquadex Platform Strategy to Expand Future Critical Care Applications

August 4, 2026 | globenewswire.com

Nuwellis Slumps on Share Sale

July 31, 2026 | baystreet.ca

Nuwellis Prices $3.4 Million Direct Offering, Receives Warrant Proceeds

July 31, 2026 | finance.yahoo.com

Nuwellis announces pricing of $3.4M registered direct offering priced at-the-market under Nasdaq rules

July 31, 2026 | seekingalpha.com

Nuwellis Announces Pricing of $3.4 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

July 31, 2026 | globenewswire.com

Nuwellis Announces Acceptance by Frontiers in Pediatrics of New Single-Center Retrospective Study Supporting Alternative Anticoagulation Strategy for Aquadex Ultrafiltration ...

July 30, 2026 | markets.businessinsider.com

Nuwellis Stock Explodes Thursday: What's Driving the Action?

July 30, 2026 | benzinga.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

NUWE, IRIX, ADGM, and MBAI Company Descriptions

Adagio Medical NASDAQ:ADGM

$0.48 -0.04 (-7.21%)

Closing price 09/18/2026 04:00 PM Eastern

Extended Trading

$0.50 +0.02 (+4.66%)

As of 09/18/2026 05:30 PM Eastern

Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and accessories; vCLAS ventricular ULTC catheter; and Cryopulse atrial pulsed-field cryoablation catheter and accessories. The company is based in Laguna Hills, California.

IRIDEX NASDAQ:IRIX

$0.67 +0.02 (+2.81%)

Closing price 09/18/2026 04:00 PM Eastern

Extended Trading

$0.66 -0.01 (-2.09%)

As of 09/18/2026 07:13 PM Eastern

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.

Check-Cap NASDAQ:MBAI

$6.39 +0.05 (+0.79%)

Closing price 09/18/2026 04:00 PM Eastern

Extended Trading

$6.35 -0.04 (-0.63%)

As of 09/18/2026 04:10 PM Eastern

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.

Nuwellis NASDAQ:NUWE

$0.90 -0.19 (-17.71%)

Closing price 09/18/2026 04:00 PM Eastern

Extended Trading

$0.84 -0.06 (-6.58%)

As of 09/18/2026 07:59 PM Eastern

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter. The company sells its products to hospitals and clinics through its direct salesforce in the United States; and through independent specialty distributors in Austria, Belarus, Brazil, Colombia, the Czech Republic, Germany, Greece, Hong Kong, India, Israel, Italy, Panama, Romania, Singapore, Slovakia, Spain, Switzerland, Thailand, the United Arab Emirates, and the United Kingdom. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest NUWE, IRIX, ADGM, and MBAI Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest NUWE, IRIX, ADGM, and MBAI Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

NUWE, IRIX, ADGM, and MBAI Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

NUWE, IRIX, ADGM, and MBAI Company Descriptions

Adagio Medical NASDAQ:ADGM

IRIDEX NASDAQ:IRIX

Check-Cap NASDAQ:MBAI

Nuwellis NASDAQ:NUWE

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest NUWE, IRIX, ADGM, and MBAI Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest NUWE, IRIX, ADGM, and MBAI Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

NUWE, IRIX, ADGM, and MBAI Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

NUWE, IRIX, ADGM, and MBAI Company Descriptions

Adagio Medical NASDAQ:ADGM

IRIDEX NASDAQ:IRIX

Check-Cap NASDAQ:MBAI

Nuwellis NASDAQ:NUWE

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools